Scale -


  • Revenue is 7.87 Rs Cr; Annual Growth is 38 %; Continuous Growth over 3 years; 5 Year CAGR is 35 %; in Bottom Quartile
  • Ebitda is 0.99 Rs Cr; Annual Growth is 48 %; Continuous Growth over 3 years; 5 Year CAGR is 26 %; in Bottom Quartile
  • PBT is 0.27 Rs Cr; Annual Growth is 48 %; 5 Year CAGR is 26 %
  • PAT is 0.74 Rs Cr; Annual Growth is 48 %; Continuous Growth over 3 years; 5 Year CAGR is 26 %
  • Quarterly Revenue is 2.55 Rs Cr; in Bottom Quartile
  • Quarterly Ebitda is 0.25 Rs Cr; in Bottom Quartile

Profitability -


  • PBDIT Margin is 12.6 %; Continuous Growth over 3 years
  • PAT Margin is 9.35 %; Continuous Growth over 3 years

Return -


  • ROCE is 54.86 %; in Top Quartile; 5 Year CAGR is -29 %
  • ROA is 20.16 %; in Top Quartile
  • ROE is 40.9 %; in Top Quartile; 5 Year CAGR is -29 %
  • Asset Turnover is 266 %; in Top Quartile

Efficiency -


  • Inventory Turnover Ratio is 19.81; Annual Growth is 44 %; Continuous Growth over 3 years; in Top Quartile
  • Operating cash flow is 0.17 Rs Cr; Annual Growth is 70 %; Continuous Growth over 3 years
  • Current Ratio is 1.96; Continuous Growth over 3 years; in Bottom Quartile
  • Quick Ratio is 1.76; Continuous Growth over 3 years; 5 Year CAGR is 24 %

Solvancy -


Quality -


  • Operating cashflow/ebitda is 17 %; Continuous Growth over 3 years
  • Operating cashflow/PAT is 23 %; Continuous Growth over 3 years
  • Current Tax/PAT is 34 %; Continuous Decline over 3 years
  • Change in Inventories/Total Expenses is 1 %; Annual Growth is 246 %; Continuous Growth over 3 years
  • Exceptional Items/PBT is 0 %; in Top Quartile
  • Other Expenses/Total Expenses is 60 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem


Sector
Major Subsidiaries/Associates
Key Clients

Products


Products
Product details

Operations


Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Nexus Surgical and Medicare Limited Estimates – BSE:NEXUSSURGL